Related Experiment Video
Updated: Dec 13, 2025

10:16
Primary Cell Cultures to Study the Regeneration Potential of Murine Müller Glia after MicroRNA Treatment
Published on: March 28, 2022
3.6K
OTX2 Non-Cell Autonomous Activity Regulates Inner Retinal Function
Raoul Torero Ibad1, Bilal Mazhar1, Clémentine Vincent1
1Centre for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, UMR 7241, INSERM U1050, Labex MemoLife, Université PSL (Paris Sciences & Lettres), 75005 Paris, France.
Eneuro
|August 2, 2020
Summary
Extracellular OTX2 (orthodenticle homeobox 2) promotes retinal cell survival. Neutralizing extracellular OTX2 in mice reduced visual acuity and altered inner retinal function.
Area of Science:
- Neuroscience
- Ophthalmology
- Genetics
Background:
- OTX2 is a homeoprotein transcription factor crucial for retinal development.
- It exhibits non-cell autonomous activity, influencing cells beyond its expression site.
- Retinal ganglion cell survival is promoted by extracellular OTX2.
Purpose of the Study:
- To investigate the role of extracellular OTX2 in postnatal retinal function.
- To assess the impact of neutralizing OTX2's non-cell autonomous activity in vivo.
Main Methods:
- Genetic targeting of extracellular OTX2 using a secreted single-chain anti-OTX2 antibody in mice.
- Assessment of visual acuity, retinal structure, and cell types.
- Electrophysiological recordings (electroretinogram) to evaluate retinal function.
Main Results:
- Expression of the anti-OTX2 antibody led to reduced visual acuity in 1-month-old mice.
- No significant alterations in retinal structure or cell populations were observed.
- Electroretinogram showed no deficits in photoreceptor or bipolar cell function, but altered inner retinal function.
Conclusions:
- Interfering with extracellular OTX2 activity in the postnatal retina impacts inner retinal function.
- Non-cell autonomous OTX2 activity is critical for maintaining normal visual acuity.
- Targeting extracellular OTX2 offers a potential avenue for understanding and treating visual deficits.

